Open in Screener

TEM

Tempus AI Inc

Feb 20 • 04:00PM ET

58.37

-1.59 -2.65 %

Healthcare • Health Information Services • USA • NASD

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK VXF BAI IBB IWP JTEK

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	41.52%	Shs Outstand	172.63M	Perf Week	14.95%
Market Cap	10.38B	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-2.68%	Shs Float	104.04M	Perf Month	-10.64%
Enterprise Value	10.96B	PEG	-	EPS next Q	-0.04	Inst Own	51.32%	Short Float	20.70%	Perf Quarter	-12.58%
Income	-203.88M	P/S	9.40	EPS this Y	61.51%	Inst Trans	7.39%	Short Ratio	4.44	Perf Half Y	-20.35%
Sales	1.11B	P/B	20.42	EPS next Y	62.47%	ROA	-12.53%	Short Interest	21.54M	Perf YTD	-1.15%
Book/sh	2.86	P/C	13.67	EPS next 5Y	-	ROE	-72.61%	52W High	104.32 -44.05%	Perf Year	-23.92%
Cash/sh	4.27	P/FCF	-	EPS past 3/5Y	-37.97% -32.48%	ROIC	-11.13%	52W Low	36.22 61.15%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	39.06% 38.58%	Gross Margin	60.33%	Volatility	5.98% 6.24%	Perf 5Y	-
Dividend TTM	-	EV/Sales	9.92	EPS Y/Y TTM	76.81%	Oper. Margin	-21.07%	ATR (14)	3.78	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.12	Sales Y/Y TTM	72.58%	Profit Margin	-18.45%	RSI (14)	48.29	Recom	1.83
Dividend Gr. 3/5Y	- -	Current Ratio	3.28	EPS Q/Q	0.15%	SMA20	0.68%	Beta	5.13	Target Price	86.71
Payout	-	Debt/Eq	2.63	Sales Q/Q	84.72%	SMA50	-7.87%	Rel Volume	1.62	Prev Close	59.96
Employees	2400	LT Debt/Eq	2.61	Earnings	Feb 24 AMC	SMA200	-16.78%	Avg Volume	4.85M	Price	58.37
IPO	Jun 14, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.16% 1.67%	Trades		Volume	7,875,029	Change	-2.65%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-19-26	Initiated	Mizuho	Outperform	$100
Feb-17-26	Initiated	Robert W. Baird	Outperform	$59
Dec-02-25	Resumed	Morgan Stanley	Overweight	$85
Oct-21-25	Downgrade	TD Cowen	Buy → Hold	$88
Oct-20-25	Initiated	Canaccord Genuity	Buy	$110
Sep-02-25	Initiated	H.C. Wainwright	Buy	$90
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44

Show Previous Ratings

Today 08:30AM	Consumer Tech News (Feb 16-20): Big Techs To Boost AI in India, EV Policy Shifts & More (Benzinga)
Feb-20-26 10:55AM	Hims & Hers Accelerates AI Preventive Care and Platform Strategy (Zacks)
09:04AM	AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech (Zacks)
Feb-19-26 03:19PM	2 Tech Bets Cathie Wood is Quietly Trimming Right Now: Should You Too? (Barchart) +6.77%
02:01PM	Tempus Shares Jump On AI Cancer Tool (GuruFocus.com)
12:04PM	Loading…
12:04PM	Tempus AI Stock Jumps As Mizuho Starts Coverage, Earnings Scheduled For Next Week (Benzinga)
09:40AM	Shopify, eBay upgraded: Wall Street's top analyst calls (The Fly)
09:15AM	Unlocking Q4 Potential of Tempus (TEM): Exploring Wall Street Estimates for Key Metrics (Zacks)
08:09AM	Here Are Thursdays Top Wall Street Analyst Research Calls: Analog Devices, Chewy, Credo Technology, eBay, Fiverr, Shopify, Verizon, and More (24/7 Wall St.)
Feb-18-26 11:52AM	Why Tempus AI Stock Is Up Today And What to Watch Before Next Weeks Earnings (24/7 Wall St.) +6.85%
11:12AM	What's Going On With Tempus AI Stock Today? (Benzinga)
09:41AM	Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy? (Zacks)
08:30AM	Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm (Business Wire)
Feb-17-26 04:44PM	Cathie Wood Adds 210K Shares to a Rising AI Bet With Upside of 102% (Barchart)
11:32AM	Market Movers: Citi Bullish on NVDA Heading into Earnings (24/7 Wall St.)
11:20AM	Loading…
11:20AM	Tempus AI & Median Partner to Add AI Lung Cancer Screening to Pixel (Zacks)
09:43AM	Dollar General downgraded, Dollar Tree upgraded: Wall Street's top analyst calls (The Fly)
07:49AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Albemarle, BitGo Holdings, Chevron, Dollar General, Equifax, Shopify, Southwest Airlines, Visa, and More (24/7 Wall St.)
Feb-13-26 09:33AM	Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release? (Zacks)
Feb-12-26 09:22PM	Cathie Wood's Ark Scoops Up $12.4 Million In Beaten-Down Robinhood - Dumps More Airbnb Shares (Benzinga) -5.28%
04:05PM	Tempus Announces Collaboration with Median Technologies to Integrate AI-Powered Lung Cancer Screening into the Pixel Platform (Business Wire)
04:05PM	Median Technologies Announces Collaboration With Tempus to Expand Access to eyonis LCS Software as a Medical Device in the United States (Business Wire)
Feb-11-26 11:13AM	HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? (Zacks)
Feb-10-26 09:54AM	Jim Cramer on Tempus (TEM): "It's Going to Go Back Down Again" (Insider Monkey)
08:30AM	Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24 (Business Wire)
Feb-04-26 10:17PM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
07:00AM	Ambry's Contributions to MAVEs Support Thousands of Patient Reclassifications and Expand to New Genes (Business Wire)
Feb-02-26 07:00AM	Ambry Genetics Announces One Millionth Test Leveraging RNA to Improve Diagnostic Accuracy and Yield (Business Wire)
Feb-01-26 06:50PM	Here Are Congresswoman Nancy Pelosi's Initial Stock Moves in 2026: They Include Nvidia, Alphabet, and Amazon Stocks, and Others (Motley Fool)
08:30AM	Tempus AI, Inc. (TEM) Strengthens Precision Medicine with New Tools, Partnerships, and Growth Milestones (Insider Monkey)
09:25AM	Loading…
Jan-29-26 09:25AM	AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift (PR Newswire)
08:47AM	TEM vs. DOCS: Which Medical-Tech Stock Looks Promising Amid AI Boom? (Zacks)
Jan-27-26 11:09AM	Nancy Pelosi Just Doubled Down on AI Again (24/7 Wall St.)
08:30AM	Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers (Business Wire)
Jan-26-26 08:56PM	Cathie Wood Bets Big On AI Trifecta: Ark Deploys $1.4 Million Across Medical, Autonomous Driving Sectors (Benzinga)
06:18PM	Pelosi's Bullish 2026 Buy List: AI, Power & Dividends (MarketBeat)
02:21PM	Nancy Pelosi Discloses New Stock Trades: Here's What She's Loading Up On - And What's She's Selling (Benzinga)
01:26PM	Natural Gas Rallies 30%, Silver Jumps 13% To $116: What's Moving Markets Monday? (Benzinga)
10:20AM	Hims & Hers Scales Platform-Led Digital Healthcare Access and Care (Zacks)
09:40AM	How TEM Is Capitalizing on AI-Driven Pathology Market Growth (Zacks)
Jan-22-26 09:06PM	Cathie Wood Loads Up On This Robotaxi Stock, Ark Dumps Roku In Latest Trades (Benzinga)
12:42PM	HIMS vs. TEM: Which Health-Tech Stock Looks More Compelling? (Zacks)
10:10AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-21-26 09:06PM	Cathie Wood Doubles Down On Netflix Despite Weak Guidance, Ark Invest Dumps This Social Media Stock (Benzinga)
04:58PM	Cathie Wood Has 13 Big Ideas For 2026: Here's The Ark Invest List And Stocks To Watch (Benzinga)
08:30AM	Tempus Announces the Launch of Paige Predict (Business Wire)
07:57AM	Tempus AI's Key 2025 Milestones Continue to Gain Industry Attention (Zacks)
Jan-20-26 12:05AM	Cathie Wood's Ark Unleashes Cryptic ARKmoji Teasers To Showcase Its 'Big Ideas' For 2026: Can You Take A Guess At The Hidden Meaning? (Benzinga) -5.05%
Jan-13-26 07:48AM	Tempus AI (TEM) Soars 15% on $1.1-Billion Deal (Insider Monkey)
07:30AM	TEM's Collab for Oncology Patient Population Is Gaining Attention (Zacks)
Jan-12-26 07:27PM	Why Tempus AI Stock Rose Today (Motley Fool)
04:18PM	JPM Preannouncements: Why Alnylam And Sarepta Lost, But Day One Won (Investor's Business Daily)
02:53PM	Why Tempus AI Stock Is Trading Higher On Monday? (Benzinga)
01:35PM	Why Tempus AI Stock Jumped on Monday? (GuruFocus.com)
01:08PM	Tempus AI's Pharma Momentum Accelerates (GuruFocus.com)
12:43PM	Gold, Silver Spike To Record Highs As Fed Independence Falters: What's Moving Markets Monday? (Benzinga)
10:58AM	Nancy Pelosi's Latest Trades Are Heating Up - Tempus AI's 100% Stock Surge Is Leading The Charge (Benzinga)
10:56AM	JPM Preannouncements Take Their Toll As Alnylam Slides, Tempus, Day One Pop (Investor's Business Daily)
08:30AM	Tempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology (Business Wire)
07:51AM	Tempus AI Stock Rallies 105% in a Year: Should Investors Still Hold? (Zacks)
07:00AM	Northwestern Medicine Selects Tempus to Expand Genomic Testing (Business Wire)
05:47AM	Tempus AI Stock Soars After Posting Triple-Digit Diagnostics Growth (Benzinga)
05:33AM	Stock Market Today: Dow Jones, S&P 500 Futures Tumble As DOJ Serves Federal Reserve-Vistra, Tempus AI, Alibaba In Focus (Benzinga)
Jan-11-26 05:30PM	Tempus Achieves Record Total Contract Value Exceeding $1.1 Billion (Business Wire)
05:00PM	Tempus Announces Preliminary Fourth Quarter and Full Year 2025 Results (Business Wire)
Jan-09-26 07:45AM	Tempus AI Stock Surges 82.4% in a Year: What's Driving It? (Zacks)
Jan-08-26 06:18PM	Inverse Cramer Wins Again: Opposite Picks Of Investor Beat Nancy Pelosi In 2025 (Benzinga)
08:30AM	Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO Gastrointestinal Cancers Symposium (Business Wire)
Jan-07-26 07:33AM	TEM's Stable Solvency and Financial Strength Are Gaining Attention (Zacks)
Jan-06-26 08:30AM	Tempus to Present at 44th Annual J.P. Morgan Healthcare Conference (Business Wire) +7.48%
Jan-05-26 12:43PM	Hims & Hers Expands Data-Driven, AI-Enabled Care and Personalization (Zacks)
Jan-02-26 09:10AM	TD Cowen Reaffirms Hold Rating on Tempus AI (TEM), Cites the Company's Position to be a Leader (Insider Monkey) +5.61%
Dec-30-25 11:47PM	Canaccord Lowers Price Objective On Tempus AI, Inc. (TEM) (Insider Monkey)
07:32AM	How Tempus AI Is Building Scale While Near-Term Risks Persist (Zacks)
Dec-29-25 08:48AM	TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside (Zacks)
Dec-26-25 07:18AM	How Tempus AI Is Advancing Toward Regulatory Pricing Catch-Up (Zacks)
Dec-22-25 10:19PM	BofA and JPMorgan Lower Tempus AI, Inc. (TEM) Price Targets on Valuation Concerns (Insider Monkey)
09:53AM	JPMorgan Lowers Tempus AI (TEM) PT to $80, Maintains Neutral Rating (Insider Monkey)
Dec-19-25 07:36AM	Tempus AI Approaching Profitability Despite GAAP Losses (Zacks)
Dec-17-25 11:22AM	Tempus AI Turns Non-GAAP Profit on Surging Genomics and Data (Zacks) -5.13%
Dec-16-25 12:11PM	Hims & Hers Scales Technology-Driven Care as Profitability Evolves (Zacks)
10:40AM	Tempus AI price target lowered to $80 from $90 at BofA (TipRanks)
09:07AM	Tempus AI Revenue Jumps 85% as Pricing Catalysts Line Up (Zacks)
08:13AM	3 MedTech Stocks Poised to Gain in 2026 From the AI Boom (Zacks)
Dec-15-25 11:30AM	Tempus AI Near $75 Target? Valuation, Upside and Risks (Zacks)
Dec-11-25 07:10AM	Tempus AI's Strategic Push to Expand Beyond Oncology (Zacks)
Dec-10-25 07:37AM	Is TEM Stock a Buy, Hold, or Sell During Its Pivotal Transition? (Zacks)
Dec-09-25 11:17AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
10:19AM	Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run? (Zacks)
08:30AM	Tempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium (Business Wire)
Dec-08-25 02:08PM	5 Tech Stocks Insiders Are Selling (But Smart Investors Are Loading Up) (MarketBeat)
10:15AM	Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook (Zacks)
Dec-05-25 09:41AM	Tempus AI: Revenue Mix and 2026 Growth Outlook Explained (Zacks)
09:25AM	Is Tempus AI the Next Big Artificial Intelligence Stock to Buy? (Motley Fool)
08:44AM	Tempus AI Boosts Its Clinical AI Capabilities Through Strategic Moves (Zacks)
Dec-04-25 11:30AM	Why Is Tempus (TEM) Down 8.9% Since Last Earnings Report? (Zacks)
10:38AM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
Dec-01-25 05:28AM	Cathie Wood's Health Tech Bet: Why Analysts See Long-Term Upside in Tempus AI (TEM) (Insider Monkey)
Nov-28-25 03:18PM	Why Tempus AI Stock Soared This Week (Motley Fool)
Nov-25-25 12:28PM	Hims & Hers Expands Care Scope as Digital Health Platforms Evolve (Zacks)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '26	Sale	58.87	166,250	9,787,605	8,908,283	Feb 20 09:45 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '26	Sale	59.05	13,587	802,312	1,989,626	Feb 20 09:45 PM
Phelps Erik	EVP, Chief Admin. Officer	Feb 19 '26	Sale	59.43	9,464	562,472	79,816	Feb 20 06:45 PM
Bartolucci Ryan M	Chief Accounting Officer	Feb 19 '26	Sale	59.05	2,902	171,363	41,159	Feb 20 06:45 PM
Polovin Andrew	EVP, Chief Legal Officer	Feb 20 '26	Sale	60.31	10,949	660,292	126,918	Feb 20 06:45 PM
Polovin Andrew	EVP, Chief Legal Officer	Feb 19 '26	Sale	59.05	8,143	480,844	99,447	Feb 20 06:45 PM
Fukushima Ryan	Chief Executive Officer, Data	Feb 19 '26	Sale	59.05	9,592	566,408	694,354	Feb 20 06:45 PM
Rogers James William	Chief Financial Officer	Feb 19 '26	Sale	59.05	10,084	595,460	101,166	Feb 20 06:45 PM
ERIK PHELPS	Officer	Feb 20 '26	Proposed Sale	59.96	3,823	229,227		Feb 20 04:28 PM
ANDREW POLOVIN	Officer	Feb 20 '26	Proposed Sale	59.96	10,949	656,502		Feb 20 04:25 PM
Ryan M. Bartolucci	Officer	Feb 19 '26	Proposed Sale	56.16	2,902	162,976		Feb 19 09:24 PM
Andrew Polovin	Officer	Feb 19 '26	Proposed Sale	56.16	8,143	457,311		Feb 19 09:22 PM
Eric Paul Lefkofsky	Officer	Feb 19 '26	Proposed Sale	56.16	13,587	763,046		Feb 19 09:20 PM
Ryan Fukushima	Officer	Feb 19 '26	Proposed Sale	56.16	9,592	538,687		Feb 19 09:17 PM
Erik Phelps	Officer	Feb 19 '26	Proposed Sale	56.16	5,650	317,304		Feb 19 09:15 PM
James William Rogers	Officer	Feb 19 '26	Proposed Sale	56.16	10,084	566,317		Feb 19 09:13 PM
ERIK PHELPS	Officer	Feb 19 '26	Proposed Sale	56.16	3,814	214,194		Feb 19 04:43 PM
Eric Lefkofsky	Officer	Feb 19 '26	Proposed Sale	56.16	166,250	9,336,600		Feb 19 04:08 PM
Tempus AI, Inc.	10% Owner	Nov 18 '25	Buy	7.67	64,750	496,632	12,783,550	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 25 '25	Buy	10.62	23,600	250,665	12,918,346	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 22 '25	Buy	8.93	28,000	250,040	13,039,067	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 21 '25	Buy	9.40	26,499	249,190	12,869,521	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 24 '25	Buy	9.87	25,225	248,971	12,894,746	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 19 '25	Buy	8.12	30,645	248,837	12,814,195	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Nov 20 '25	Buy	8.63	28,827	248,777	12,843,022	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 17 '25	Buy	7.86	31,650	248,769	12,949,996	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 19 '25	Buy	8.39	29,641	248,688	13,011,067	Feb 13 05:24 PM
Tempus AI, Inc.	10% Owner	Dec 18 '25	Buy	7.91	31,430	248,611	12,981,426	Feb 13 05:24 PM
Epstein David R	Director	Feb 02 '26	Sale	59.41	370	21,982	26,051	Feb 04 04:30 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jan 28 '26	Sale	65.56	166,250	10,899,207	8,941,533	Jan 30 04:15 PM
Eric Lefkofsky	Officer	Jan 28 '26	Proposed Sale	66.81	166,250	11,107,162		Jan 28 04:21 PM
Fukushima Ryan	Chief Operating Officer	Jan 05 '26	Sale	64.26	5,000	321,300	148,808	Jan 07 06:25 PM
Doudna Jennifer A	Director	Jan 02 '26	Sale	60.17	1,250	75,212	22,702	Jan 06 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Dec 18 '25	Sale	63.99	166,250	10,638,478	8,974,783	Dec 22 05:41 PM
Eric Lefkofsky	Officer	Dec 18 '25	Proposed Sale	64.61	166,250	10,741,413		Dec 18 04:39 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Dec 16 '25	Sale	67.42	1,302	87,781	89,280	Dec 18 04:15 PM
ERIK PHELPS	Officer	Dec 16 '25	Proposed Sale	68.67	1,302	89,408		Dec 16 04:29 PM
Rogers James William	Chief Financial Officer	Dec 11 '25	Sale	73.20	19,966	1,461,479	111,250	Dec 12 04:30 PM
JAMES ROGERS	Officer	Dec 11 '25	Proposed Sale	75.07	19,966	1,498,848		Dec 11 04:23 PM
Frederick Wayne A.I.	Director	Dec 05 '25	Sale	77.23	3,675	283,820	24,836	Dec 09 04:15 PM
WAYNE FREDERICK	Director	Dec 05 '25	Proposed Sale	77.23	3,675	283,802		Dec 05 04:15 PM
Epstein David R	Director	Dec 01 '25	Sale	75.55	250	18,888	26,421	Dec 03 04:50 PM
Fukushima Ryan	Chief Operating Officer	Dec 01 '25	Sale	75.72	5,000	378,620	153,808	Dec 03 04:50 PM
Doudna Jennifer A	Director	Dec 01 '25	Sale	75.55	676	51,072	23,952	Dec 03 04:50 PM
LEFKOFSKY ERIC P	CEO and Chairman	Nov 24 '25	Sale	74.10	166,250	12,319,125	9,008,033	Nov 25 04:30 PM
Polovin Andrew	EVP and General Counsel	Nov 24 '25	Sale	75.00	12,874	965,550	107,590	Nov 25 04:30 PM
Eric Lefkofsky	Officer	Nov 20 '25	Proposed Sale	70.40	166,250	11,703,285		Nov 24 06:11 PM
ANDREW POLOVIN	Officer	Nov 24 '25	Proposed Sale	70.29	12,874	904,913		Nov 24 04:29 PM
LEFKOFSKY ERIC P	CEO and Chairman	Nov 20 '25	Sale	68.97	166,250	11,466,099	9,041,283	Nov 20 07:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Nov 18 '25	Sale	65.54	16,829	1,102,944	2,003,213	Nov 20 07:56 PM
Rogers James William	Chief Financial Officer	Nov 18 '25	Sale	65.54	7,257	475,611	131,216	Nov 20 07:05 PM
Polovin Andrew	EVP and General Counsel	Nov 19 '25	Sale	68.06	6,387	434,707	120,464	Nov 20 07:05 PM
Polovin Andrew	EVP and General Counsel	Nov 18 '25	Sale	65.54	5,205	341,126	126,851	Nov 20 07:05 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Nov 18 '25	Sale	65.54	3,533	231,547	90,582	Nov 20 07:05 PM
Fukushima Ryan	Chief Operating Officer	Nov 18 '25	Sale	65.54	10,099	661,870	829,081	Nov 20 07:05 PM
Bartolucci Ryan M	Chief Accounting Officer	Nov 18 '25	Sale	65.54	1,834	120,197	44,061	Nov 20 07:05 PM
Eric Lefkofsky	Officer	Nov 20 '25	Proposed Sale	69.09	166,250	11,486,212		Nov 20 04:46 PM
ANDREW POLOVIN	Officer	Nov 19 '25	Proposed Sale	66.77	6,387	426,460		Nov 19 04:22 PM
Ryan M. Bartolucci	Officer	Nov 18 '25	Proposed Sale	66.39	1,834	121,759		Nov 18 07:09 PM
Ryan Fukushima	Officer	Nov 18 '25	Proposed Sale	66.39	10,099	670,473		Nov 18 07:08 PM
Eric Paul Lefkofsky	Officer	Nov 18 '25	Proposed Sale	66.39	16,829	1,117,277		Nov 18 07:07 PM
Andrew Polovin	Officer	Nov 18 '25	Proposed Sale	66.39	5,205	345,560		Nov 18 07:05 PM
James William Rogers	Officer	Nov 18 '25	Proposed Sale	66.39	7,257	481,792		Nov 18 07:04 PM
Erik Phelps	Officer	Nov 18 '25	Proposed Sale	66.39	3,533	234,556		Nov 18 07:03 PM
Doudna Jennifer A	Director	Nov 11 '25	Sale	71.45	1,926	137,613	24,628	Nov 13 04:15 PM
JENNIFER DOUDNA	Director	Nov 11 '25	Proposed Sale	71.78	3,852	276,497		Nov 12 07:03 AM
Fukushima Ryan	Chief Operating Officer	Nov 03 '25	Sale	89.03	5,000	445,160	125,000	Nov 05 04:15 PM
Epstein David R	Director	Nov 03 '25	Sale	90.00	370	33,300	26,671	Nov 05 04:15 PM
VANESSA L KUBO	Officer	Nov 03 '25	Proposed Sale	89.85	20,000	1,797,000		Nov 03 04:26 PM
DAVID R. EPSTEIN	Director	Nov 03 '25	Proposed Sale	89.85	990	88,952		Nov 03 04:25 PM
LEFKOFSKY ERIC P	CEO and Chairman	Oct 28 '25	Sale	89.11	332,500	29,629,006	9,074,532	Oct 30 04:31 PM
Eric Lefkofsky	Officer	Oct 28 '25	Proposed Sale	91.58	332,500	30,450,350		Oct 28 04:09 PM
Fukushima Ryan	Chief Operating Officer	Oct 06 '25	Sale	92.32	5,000	461,606	130,000	Oct 08 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Sep 25 '25	Sale	76.56	332,500	25,457,014	9,141,032	Sep 29 04:33 PM
Eric Lefkofsky	Officer	Sep 25 '25	Proposed Sale	84.13	332,500	27,973,225		Sep 25 07:04 PM
Fukushima Ryan	Chief Operating Officer	Sep 02 '25	Sale	75.80	10,000	758,028	135,000	Sep 04 04:15 PM
Epstein David R	Director	Sep 02 '25	Sale	73.64	250	18,410	27,041	Sep 04 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 27 '25	Sale	74.10	332,500	24,637,581	9,207,533	Aug 29 05:13 PM
Leonsis Theodore	Director	Aug 26 '25	Sale	75.83	20,000	1,516,600	66,756	Aug 28 04:15 PM
Eric Lefkofsky	Officer	Aug 27 '25	Proposed Sale	75.90	332,500	25,236,750		Aug 27 04:19 PM
Leonsis Theodore	Director	Aug 26 '25	Proposed Sale	75.83	20,000	1,516,650		Aug 26 01:27 PM
Polovin Andrew	EVP and General Counsel	Aug 19 '25	Sale	74.65	5,398	402,982	132,056	Aug 21 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Aug 19 '25	Sale	74.65	3,664	273,532	94,115	Aug 21 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 19 '25	Sale	74.65	17,458	1,303,307	2,020,042	Aug 21 04:15 PM
Fukushima Ryan	Chief Operating Officer	Aug 19 '25	Sale	74.65	17,460	1,303,456	839,180	Aug 21 04:15 PM
Rogers James William	Chief Financial Officer	Aug 19 '25	Sale	74.65	7,528	561,994	138,473	Aug 21 04:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Aug 19 '25	Sale	74.65	1,904	142,141	45,895	Aug 21 04:15 PM
Erik Phelps	Officer	Aug 19 '25	Proposed Sale	78.45	3,664	287,441		Aug 20 07:19 AM
Andrew Polovin	Officer	Aug 19 '25	Proposed Sale	78.45	5,398	423,473		Aug 20 07:17 AM
Ryan Fukushima	Officer	Aug 19 '25	Proposed Sale	78.45	17,460	1,369,737		Aug 20 07:15 AM
Eric Paul Lefkofsky	Officer	Aug 19 '25	Proposed Sale	78.45	17,458	1,369,580		Aug 20 07:14 AM
James William Rogers	Officer	Aug 19 '25	Proposed Sale	78.45	7,528	590,572		Aug 19 09:59 PM
Ryan M. Bartolucci	Officer	Aug 19 '25	Proposed Sale	78.45	1,904	149,369		Aug 19 09:56 PM
Leonsis Theodore	Director	Aug 13 '25	Proposed Sale	69.90	44,000	3,075,786		Aug 18 02:44 PM
Leonsis Theodore	Director	Aug 13 '25	Sale	69.90	44,000	3,075,600	86,756	Aug 15 09:21 PM
Epstein David R	Director	Aug 01 '25	Sale	55.16	370	20,409	27,291	Aug 05 04:15 PM
DAVID R. EPSTEIN	Director	Aug 01 '25	Proposed Sale	56.59	620	35,086		Aug 01 04:30 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jul 28 '25	Sale	62.87	166,250	10,452,027	9,274,033	Jul 30 08:42 PM
Eric Lefkofsky	Officer	Jul 28 '25	Proposed Sale	64.49	166,250	10,721,462		Jul 28 04:13 PM
Fukushima Ryan	Chief Operating Officer	Jul 07 '25	Sale	60.00	5,000	300,000	145,000	Jul 09 04:15 PM

Open in Screener

PFE

Pfizer Inc

Feb 20 • 04:00PM ET

26.65

-0.21 -0.78 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Index	S&P 500	P/E	19.67	EPS (ttm)	1.36	Insider Own	0.07%	Shs Outstand	5.69B	Perf Week	-2.99%
Market Cap	151.52B	Forward P/E	9.41	EPS next Y	2.83	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	2.94%
Enterprise Value	198.55B	PEG	-	EPS next Q	0.73	Inst Own	67.06%	Short Float	2.52%	Perf Quarter	4.72%
Income	7.75B	P/S	2.42	EPS this Y	-8.14%	Inst Trans	-0.20%	Short Ratio	2.92	Perf Half Y	5.00%
Sales	62.58B	P/B	1.63	EPS next Y	-4.23%	ROA	4.58%	Short Interest	143.04M	Perf YTD	7.03%
Book/sh	16.32	P/C	10.11	EPS next 5Y	-8.81%	ROE	10.59%	52W High	27.94 -4.62%	Perf Year	2.90%
Cash/sh	2.64	P/FCF	14.60	EPS past 3/5Y	-37.12% -3.51%	ROIC	5.16%	52W Low	20.92 27.42%	Perf 3Y	-38.32%
Dividend Est.	1.75 (6.57%)	EV/EBITDA	7.59	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	76.10%	Volatility	1.91% 2.23%	Perf 5Y	-22.62%
Dividend TTM	1.72 (6.45%)	EV/Sales	3.17	EPS Y/Y TTM	-3.74%	Oper. Margin	27.83%	ATR (14)	0.61	Perf 10Y	-4.64%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	-1.65%	Profit Margin	12.38%	RSI (14)	50.65	Recom	2.52
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.28	EPS Q/Q	-509.90%	SMA20	-0.38%	Beta	0.44	Target Price	28.50
Payout	126.47%	Debt/Eq	0.66	Sales Q/Q	-1.16%	SMA50	2.74%	Rel Volume	0.91	Prev Close	26.86
Employees	81000	LT Debt/Eq	0.62	Earnings	Feb 03 BMO	SMA200	7.03%	Avg Volume	49.02M	Price	26.65
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.42% 4.20%	Trades		Volume	44,733,397	Change	-0.78%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38

Show Previous Ratings

Feb-20-26 11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
10:46AM	AstraZeneca vs. Pfizer: Which Pharma Giant Has the Edge in 2026? (Zacks)
08:08AM	Barclays launches U.S. biopharma coverage with four preferred picks (Investing.com)
03:58AM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
03:34AM	Pfizer Inc (PFE) Announces Positive Results from BREAKWATER Trial (Insider Monkey)
10:15AM	Loading…
Feb-19-26 10:15AM	Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure (Zacks)
09:53AM	Where is Pfizer Inc. (PFE) Headed? (Insider Monkey)
Feb-18-26 11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
03:20AM	Analyst Report: Pfizer Inc. (Morningstar Research)
Feb-17-26 11:04AM	Hims & Hers Faces New Hurdle In Weight-Loss Brawl With Novo Nordisk (Investor's Business Daily)
10:30AM	CorMedix Down 27% in 3 Months: Is It Time to Sell the Stock? (Zacks)
10:15AM	Pfizer's Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial (Benzinga)
06:45AM	Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer (Business Wire)
Feb-14-26 02:04PM	Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25 (MarketBeat)
01:28AM	Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings (Insider Monkey)
08:57PM	Loading…
Feb-13-26 08:57PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
04:57PM	Analyst Report: Zoetis Inc. (Morningstar Research)
09:57AM	Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds? (Insider Monkey)
Feb-12-26 12:00PM	Kahn Brothers Reduces Stake in Pfizer Inc by 21.66% (GuruFocus.com)
10:38AM	MDGL Strengthens MASH Franchise With New Genetic Approaches (Zacks)
08:00AM	Here Are Thursdays Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More (24/7 Wall St.)
Feb-11-26 01:30PM	Pfizer Reports Strong Earnings Outlook - Unusual Call Options Activity Shows Investors are Bullish (Barchart)
12:57PM	Pharma companies left out of Trump's drug-pricing deals look for way in (Reuters)
10:35AM	Pfizer (PFE) Closes 2025 on Solid Note, Returns $9.8B to Shareholders (Insider Monkey)
08:09AM	Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff? (Zacks)
08:01AM	CorMedix Banks on DefenCath Sales in Q4 as Melinta Adds Upside (Zacks)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
11:06AM	Will BMY's Legacy Portfolio Decline Weigh on Its 2026 Top Line? (Zacks)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
06:41AM	Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI (marstacimab) sBLA (Insider Monkey)
12:37AM	Loading…
12:37AM	5 Revealing Analyst Questions From Pfizer's Q4 Earnings Call (StockStory)
Feb-09-26 10:29AM	BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
09:11AM	Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4? (Zacks)
Feb-07-26 08:00AM	Pfizer CEO discusses the company's GLP-1 weight-loss drug pipeline (Yahoo Finance Video)
Feb-06-26 05:13PM	TrumpRx Is Here. Most People Won't Benefit. (Barrons.com)
03:37PM	3 High-Yield Dividend Stocks Perfect For Retirees (24/7 Wall St.)
11:58AM	TrumpRx launches to slash drug prices for cash-paying US patients (Pharmaceutical Technology)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
08:00AM	China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse. (Investor's Business Daily)
07:45AM	5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now (24/7 Wall St.)
07:08AM	White Houses online service for drug sales debuts with limited impact on prices (BioPharma Dive)
06:45AM	FDA Grants Priority Review for HYMPAVZI (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need (Business Wire)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
Feb-05-26 09:17PM	Trump launches TrumpRX website offering discounted prescription drugs (Investing.com)
08:06PM	Adaptive Biotechnologies Q4 Earnings Call Highlights (MarketBeat)
07:09PM	Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans (Business Wire)
05:22PM	Pfizer Pops on Q4 Results-But This May Be the Catalyst That Matters Most (MarketBeat)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
01:29PM	Bristol Myers Earnings Reveal Struggling Legacy Drug Business. Why the Stock Is Rising. (Barrons.com)
10:49AM	Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates (Zacks)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
08:21AM	The Week Ahead: Inflation Data Hits Amid Earnings Season (Schaeffer's Research)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
03:00AM	Big Pharma CEOs set sights on massive growth in years to come (Pharma Voice)
Feb-04-26 09:35PM	Pfizer Inc. (PFE): A Bull Case Theory (Insider Monkey)
01:11PM	Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss (Insider Monkey)
11:40AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
08:45AM	Novo Nordisk: Pfizer weight loss drug offers credible new competition (Proactive)
04:51AM	Earnings roundup: Amgen vs. FDA, Pfizers defense and Mercks $70B-in-sales plan (BioPharma Dive)
01:08AM	Pfizer Q4 Earnings Call Highlights (MarketBeat)
12:32AM	PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds (StockStory)
Feb-03-26 11:35PM	Will the Market Crash in 2026? Here's What History Says and What to Do About It (Motley Fool)
11:09PM	Asian shares gained and gold and silver climb higher after a retreat on Wall St (Associated Press Finance)
09:49PM	Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off (Motley Fool)
06:03PM	Stocks to Watch Tuesday Recap: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
04:36PM	These Stocks Are Todays Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More (Barrons.com)
04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
04:09PM	Pfizer Dives; Why Lilly's Zepbound Still Looks Like The Weight-Loss Heavyweight (Investor's Business Daily)
04:03PM	Pfizer Inc (PFE) Q4 2025 Earnings Call Highlights: Strategic Acquisitions and Revenue Guidance ... (GuruFocus.com)
03:14PM	Analyst Report: Pfizer Inc. (Morningstar Research)
03:05PM	Stocks to Watch Tuesday: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
02:57PM	These Are The Worst 25 Stocks to Own in February (Schaeffer's Research)
02:48PM	Obesity Drug Bets Get a Reality Checkbut Investors Shouldnt Panic (The Wall Street Journal)
02:24PM	Stock market today: Dow, Nasdaq, S&P 500 sink as tech falters amid flood of earnings (Yahoo Finance)
02:06PM	Pfizer is at 'the end of the beginning' in entry to GLP-1s: CEO (Yahoo Finance Video)
01:59PM	Pfizer sets sights on R&D strategy amid modest FY25 results (Pharmaceutical Technology)
12:33PM	Stock market today: Nasdaq, S&P 500 slide as investors digest flood of tech earnings, government shutdown (Yahoo Finance)
12:33PM	Stock market today: Dow, Nasdaq, S&P 500 fall as investors digest flood of tech earnings, government shutdown (Yahoo Finance)
12:22PM	Pfizer Releases Early Obesity Data Showing Up to 12.3% Weight Loss (GuruFocus.com)
11:40AM	Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways (CNBC TV)
11:36AM	Why Pfizer Stock Dropped Today (Motley Fool)
11:32AM	Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data (Zacks)
11:30AM	Why Is Pfizer Stock Sliding Today (GuruFocus.com)
11:04AM	2 Pharma Stocks React to Quarterly Results, Guidance (Schaeffer's Research)
11:00AM	Market Awaits JOLTS Jobs Report (Zacks)
10:48AM	Pfizer shares drop on quarterly loss (AFP)
10:40AM	Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook (CNBC TV)
10:35AM	Pfizer Projects Revenue Dip in 2026 as Patent Losses Weigh (GuruFocus.com)
10:32AM	Pfizer Stock Drops On Obesity-Drug Study Data (The Wall Street Journal)
10:26AM	Q4 Earnings, JOLTS & a Changing of the Disney Guard (Zacks)
09:59AM	Pfizer Targets Monthly Obesity Shot. Why Lilly Could Still Have The Weight-Loss Heavyweight. (Investor's Business Daily)
09:36AM	Stock market today: Nasdaq, S&P 500 fall as investors digest flood of tech earnings, partial government shutdown (Yahoo Finance)
09:36AM	Stock market today: Dow, S&P 500, Nasdaq edge higher as Palantir lifts tech hopes, earnings flood in (Yahoo Finance)
09:30AM	Pfizer (PFE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:02AM	S&P 500, Nasdaq poised for higher open as earnings deluge takes center stage (Reuters)
08:50AM	Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops (Benzinga)
08:19AM	Pharma stocks slump as Pfizer and Merck report earnings (Quartz)
08:19AM	Merck and Pfizer decline vs the broader market as results released (Quartz)
07:55AM	Pfizer (PFE) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:38AM	Pfizer Reaffirms FY26 Outlook As Q4 Results Top Estimates - Update (RTT News)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM

TEM

Tempus AI Inc

PFE

Pfizer Inc

Upgrade your FINVIZ experience